(Q37528649)

20 August 2017

Somatotroph pituitary adenoma with acromegaly and autosomal dominant polycystic kidney disease: SSTR5 polymorphism and PKD1 mutation (English)

1 reference

autosomal dominant polycystic kidney disease

20 August 2017

1 reference

autosomal dominant polycystic kidney

inferred from title

1 reference

1 reference

Bernd Walter Scheithauer

3

object named as

Bernd W Scheithauer

1 reference

20 August 2017

13

Kalman Kovacs

1 reference

20 August 2017

Luis V Syro

1

1 reference

20 August 2017

Jamie L Sundsbak

2

1 reference

20 August 2017

Rodrigo A Toledo

4

1 reference

20 August 2017

Mauricio Camargo

5

1 reference

20 August 2017

Christina M Heyer

6

1 reference

20 August 2017

Tomoko Sekiya

7

1 reference

20 August 2017

Humberto Uribe

8

1 reference

20 August 2017

Jorge I Escobar

9

1 reference

20 August 2017

Martin Vasquez

10

1 reference

20 August 2017

Fabio Rotondo

11

1 reference

20 August 2017

Sergio P A Toledo

12

1 reference

20 August 2017

Eva Horvath

14

1 reference

20 August 2017

Dusica Babovic-Vuksanovic

15

1 reference

20 August 2017

Peter C Harris

16

1 reference

20 August 2017

1 September 2012

1 reference

20 August 2017

1 reference

20 August 2017

15

1 reference

20 August 2017

3

1 reference

20 August 2017

342-349

1 reference

Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905832

Reducing polycystic liver volume in ADPKD: effects of somatostatin analogue octreotide

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905832

Pituitary somatostatin receptor signaling

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905832

Acromegaly pathogenesis and treatment

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905832

Autosomal dominant polycystic kidney disease: the last 3 years

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905832

Guidelines for acromegaly management: an update

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905832

Polycystic kidney disease

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905832

Preclinical and clinical experiences with the role of somatostatin receptors in the treatment of pituitary adenomas

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905832

Medical progress: Acromegaly

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905832

Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905832

Acromegaly: molecular expression of somatostatin receptor subtypes and treatment outcome

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905832

Mapping of somatostatin receptor types in GH or/and PRL producing pituitary adenomas

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905832

The role of somatostatin receptors in the medical treatment of acromegaly.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905832

Somatostatin Receptors in Pituitary and Development of Somatostatin Receptor Subtype-Selective Analogs

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905832

Mutation of somatostatin receptor type 5 in an acromegalic patient resistant to somatostatin analog treatment

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905832

New medical treatment for acromegaly

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905832

Somatostatin and its receptor family

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905832

Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905832

Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebo-controlled trial.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905832

Genetic variation in the SST gene and its receptors in relation to circulating levels of insulin-like growth factor-I, IGFBP3, and prostate cancer risk

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905832

Acromegaly: correlation between expression of somatostatin receptor subtypes and response to octreotide-lar treatment

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905832

Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905832

Pituitary adenoma predisposition caused by germline mutations in the AIP gene.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905832

Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905832

Analysis of somatostatin receptors 2 and 5 polymorphisms in patients with acromegaly.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905832

Novel polymorphisms in the somatostatin receptor 5 (SSTR5) gene associated with bipolar affective disorder

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905832

Differential inhibition of growth hormone secretion by analogs selective for somatostatin receptor subtypes 2 and 5 in human growth-hormone-secreting adenoma cells in vitro

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905832

Expression of three somatostatin receptor subtypes in pituitary adenomas: evidence for preferential SSTR5 expression in the mammosomatotroph lineage.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3905832

Hyperproliferation of PKD1 cystic cells is induced by insulin-like growth factor-1 activation of the Ras/Raf signalling system.

2 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11102-011-0325-0

Increased rate of intracranial saccular aneurysms in acromegaly: an MR angiography study and review of the literature

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11102-011-0325-0

Association between somatostatin receptor 5 gene polymorphisms and pancreatic cancer risk and survival

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11102-011-0325-0

[Hypophyseal incidentaloma in a patient with autosomal dominant polycystic kidney disease]

21 January 2018

1 reference

12 December 2020

Molecular biology of somatostatin receptors

1 reference

12 December 2020

The tuberin (TSC2), autosomal dominant polycystic kidney disease (PKD1), and somatostatin type V receptor (SSTR5) genes form a synteny group in the Fugu genome

1 reference

12 December 2020

Quantitative analysis of somatostatin receptor subtype (SSTR1–5) gene expression levels in somatotropinomas and non-functioning pituitary adenomas

1 reference

12 December 2020

Germline mutation in the aryl hydrocarbon receptor interacting protein gene in familial somatotropinoma

1 reference

12 December 2020

Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease

1 reference

12 December 2020

10.1007/S11102-011-0325-0

Identifiers

DOI

1 reference

20 August 2017

1 reference

20 August 2017

PubMed publication ID

21744088

1 reference